
|Slideshows|April 3, 2020
- Vol 37, Issue 3
- Volume 37
- Issue 3
In This Issue of Psychiatric Times: Volume 37, No 3
Author(s)Laurie Martin
Read the Psychiatric Times issue cover-to-cover, with a bonus PDF.
Advertisement
Articles in this issue
almost 6 years ago
When Baby and OCD Are on Board Assessment and Treatment Issuesalmost 6 years ago
Treatment Nonadherence: An Epidemic Hidden in Plain Sightalmost 6 years ago
Assassins in London and Washington Force Changes in the Insanity Defensealmost 6 years ago
Dear Provideralmost 6 years ago
Are We Making Any Progress in Treatment and Attitudes?almost 6 years ago
Managing Behavioral and Psychological Symptoms of Dementiaalmost 6 years ago
Reframing Our Relationship With Pharmaalmost 6 years ago
We’ve Come a Long Way . . . Or Have We?Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1
2
FDA Accepts Investigational New Drug Application for COMP360 for PTSD
3
Neurosterix Announces Phase 1 Study of NTX-253 for Schizophrenia
4
Stress in Sports: What It Really Means and How to Discuss With Athletes
5

















